Clopidogrel EP Impurity A Reference Standard: Applications in Pharmaceutical Analysis

In pharmaceutical development and quality control, the accurate identification and quantification of impurities is essential for demonstrating the safety, quality, purity, and consistency of drug products. For active pharmaceutical ingredients (APIs) such as clopidogrel, impurity profiling is an important component of analytical method development, validation, stability testing, and regulatory submissions.

Clopidogrel EP Impurity A Reference Standard is an important analytical reference material used for the detection and evaluation of a specific impurity associated with clopidogrel. Chemicea Pharmaceuticals supplies Clopidogrel EP Impurity A as part of its portfolio of pharmaceutical impurity reference standards, supporting laboratories involved in pharmaceutical analysis, quality control, research, and regulatory activities.

According to Chemicea's product information, Clopidogrel EP Impurity A is identified by CAT. No. CP-C2001, CAS No. 144457-28-3, molecular formula C15H14ClNO2S, and molecular weight 307.80 g/mol. It is also listed under the synonym Clopidogrel USP Related Compound A.

Understanding Clopidogrel and Its Impurity Profile

Clopidogrel is an antiplatelet pharmaceutical used to reduce platelet aggregation and help prevent thrombotic cardiovascular events. Because the API is manufactured through a multistep chemical process and can undergo chemical transformation during processing, storage, or formulation, pharmaceutical laboratories need appropriate analytical procedures to monitor related substances.

Impurities can originate from several sources, including starting materials, intermediates, process-related reactions, degradation pathways, residual reagents, and changes occurring during storage. Some impurities may also arise from stereochemical or chemical transformations of the API.

For this reason, impurity reference standards are indispensable in chromatographic analysis. They provide analysts with characterized materials against which peaks observed in an analytical sample can be compared.

Clopidogrel EP Impurity A represents one such important analytical marker. Chemicea identifies the material by the chemical name (2S)-2-(2-chlorophenyl)-2-[6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]acetic acid.

What Is a Pharmaceutical Impurity Reference Standard?

A pharmaceutical impurity reference standard is a chemical substance used as an analytical reference for the identification, characterization, and, where applicable, quantification of a specified impurity.

Unlike a conventional reagent, an impurity reference standard is selected specifically for analytical applications. Its identity and associated documentation allow pharmaceutical scientists to establish the relationship between a chromatographic response and a known impurity.

Reference standards can therefore support:

• Impurity identification

• Related-substance testing

• Quantitative impurity determination

• Analytical method development

• Method validation

• Stability studies

• Forced degradation investigations

• Batch-release testing

• Cleaning and process evaluation

• Regulatory documentation

For laboratories working with clopidogrel, having the appropriate impurity standard available can make analytical investigations more reliable and reproducible.

Key Specifications of Clopidogrel EP Impurity A

Chemicea's product listing provides the following information for Clopidogrel EP Impurity A:

Parameter	Information
Product	Clopidogrel EP Impurity A
CAT. No.	CP-C2001
CAS No.	144457-28-3
Molecular Formula	C15H14ClNO2S
Molecular Weight	307.80 g/mol
Synonym	Clopidogrel USP Related Compound A
Category	Impurity Standards
Chemical Name	(2S)-2-(2-chlorophenyl)-2-[6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]acetic acid
Relative CAS No.	144750-42-5 (HCl salt)